Highlights
- Triple receptor agonist targeting GLP-1, GIP, and glucagon
- Studied for roles in metabolic and glucose regulation
- Investigated in research on obesity, diabetes, and NASH
Description
Reta is an experimental peptide investigated as a triple receptor agonist, acting on GLP-1, GIP, and glucagon pathways. Research explores its role in metabolic regulation, appetite signaling, and glucose balance, with ongoing studies in areas such as diabetes, obesity, and related metabolic conditions. Supplied strictly for research use only.